Sudarshan Pharma Industries Ltd.
BSE: 543828
₹35.07
₹0.07
(0.20%)
As on 11-Jun-2026IST
Market cap
₹844 Cr
Revenue (TTM)
₹703 Cr
P/E Ratio
36.2
P/B Ratio
5.4
Div. Yield
0 %
Quality Score
1/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹23 Cr
-
ROE
13.3 %
-
ROCE
14.4 %
-
Industry P/E
36.99
-
EV/EBITDA
18.8
-
Debt to Equity
0.2
-
Book Value
₹6.4
-
EPS
₹1
-
Face value
1
-
Shares outstanding
240,658,870
10 Years Aggregate
CFO
₹10.07 Cr
EBITDA
₹106.20 Cr
Net Profit
₹46.98 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sudarshan Pharma
| 27.3 | 15.7 | 35.8 | 10.1 | 75.3 | -- | -- |
|
BSE Commodities
| 4.2 | -4.2 | 4.6 | 7.3 | 15.5 | 9.9 | 15.2 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Sudarshan Pharma
| -38.1 | 454.4 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Commodities
| 12.5 | 8.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sudarshan Pharma
|
35.1 | 844.0 | 703.1 | 23.4 | 6.8 | 15.8 | 36.2 | 5.4 |
| 427.9 | 15,499.6 | 8,302.0 | 419.0 | 8.3 | 7.1 | 37 | 2.6 | |
| 1,128.8 | 14,969.5 | 1,153.5 | 219.5 | 25.6 | 9.5 | 68.2 | 6.1 | |
| 1,258.0 | 14,306.2 | 2,365.5 | 222.2 | 16.3 | 5.2 | 84.1 | 4.3 | |
| 1,612.4 | 21,975.0 | 7,887.1 | 550.7 | 9.6 | 9.9 | 39.9 | 3.8 | |
| 4,677.1 | 14,302.9 | 2,365.8 | 420.2 | 18.0 | 16 | 34.3 | 5.4 | |
| 6,241.0 | 14,463.7 | 2,120.1 | 338.2 | 18.4 | 13.1 | 42.8 | 5.4 | |
| 617.4 | 9,857.9 | 4,388.3 | 278.1 | 8.9 | 9.3 | 35.5 | 3.2 | |
| 3,243.2 | 12,643.4 | 2,563.7 | 316.7 | 19.6 | 24.7 | 38.6 | 9.0 | |
| 1,305.4 | 13,519.6 | 2,226.9 | 443.8 | 24.4 | 14.6 | 30.5 | 4.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sudarshan Pharma
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
2008
-
Chairman
Hemal Vasantrai Mehta
-
Managing Director
Hemal Vasantrai Mehta
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Sudarshan Pharma Industries Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Sudarshan Pharma
What is the current share price of Sudarshan Pharma Industries Ltd Today?
The share price of Sudarshan Pharma Industries Ltd is ₹35.07 (BSE) as of 11-Jun-2026 IST. Sudarshan Pharma Industries Ltd has given a return of 75.3% in the last 3 years.
What is the current PB & PE ratio of Sudarshan Pharma Industries Ltd?
The P/E ratio of Sudarshan Pharma Industries Ltd is 36.22 times as on 11-Jun-2026, a 2 discount to its peers’ median range of 36.99 times.
The P/B ratio of Sudarshan Pharma Industries Ltd is 5.44 times as on 11-Jun-2026, a 119 premium to its peers’ median range of 2.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
46.06
|
5.76
|
|
2024
|
1.56
|
1.60
|
|
2023
|
19.08
|
1.33
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Sudarshan Pharma Industries Ltd?
The 52-week high and low of Sudarshan Pharma Industries Ltd are Rs 36.95 and Rs 18.50 as of 12-Jun-2026.
What is the market cap of Sudarshan Pharma Industries Ltd?
Sudarshan Pharma Industries Ltd has a market capitalisation of ₹ 844 Cr as on 11-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sudarshan Pharma Industries Ltd?
Before investing in Sudarshan Pharma Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.